Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction
Debates about the etiology of addiction have a long history and continue to the present day. In contemporary societies, the brain disease model of addiction (BDMA) continues to receive strong support, in particular, from US agencies such as the National Institute on Drug Abuse (NIDA) and the America...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Online |
| Taal: | Engels |
| Gepubliceerd in: |
Taylor & Francis
2022
|
| Onderwerpen: | |
| Online toegang: | https://library.oapen.org/handle/20.500.12657/52200 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
| _version_ | 1869518434456305664 |
|---|---|
| author | Barnett, Anthony Savic, Michael Pickersgill, Martyn O’Brien, Kerry Lubman, Dan I. Carter, Adrian |
| author_browse | Barnett, Anthony Carter, Adrian Lubman, Dan I. O’Brien, Kerry Pickersgill, Martyn Savic, Michael |
| author_facet | Barnett, Anthony Savic, Michael Pickersgill, Martyn O’Brien, Kerry Lubman, Dan I. Carter, Adrian |
| author_sort | Barnett, Anthony |
| collection | Directory of Open Access Books |
| description | Debates about the etiology of addiction have a long history and continue to the present day. In contemporary societies, the brain disease model of addiction (BDMA) continues to receive strong support, in particular, from US agencies such as the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine. Today, there continues to be a significant investment in addiction neuroscience research globally. However, the views of addiction treatment providers about the BDMA, and its clinical impact, are often ignored when debates led by public health researchers and neuroscientists dominate discourse about the neurobiology of addiction. In this chapter, we start by providing a brief history of the biomedicalization of addiction. Moving beyond the question of ‘Is addiction a brain disease, or not?’, we summarize providers’ views about the BDMA and its impact on clinical practice. Drawing on recent critical drug studies scholarship, we critique how a simplistic, linear ‘bench to bedside’ model of addiction neuroscience translation elides the role treatment providers play in translating neuroscience. Finally, we consider the effects of how the enactment of addiction as a brain disease within policy impacts treatment, and how addiction might be enacted in other ways in future policy frameworks. |
| format | Online |
| id | doab-20.500.12854ir-75215 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | Taylor & Francis |
| publisherStr | Taylor & Francis |
| record_format | ojs |
| spelling | doab-20.500.12854ir-752152025-07-30T11:56:10Z Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction Barnett, Anthony Savic, Michael Pickersgill, Martyn O’Brien, Kerry Lubman, Dan I. Carter, Adrian brain disease model; addiction; treatment thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics Debates about the etiology of addiction have a long history and continue to the present day. In contemporary societies, the brain disease model of addiction (BDMA) continues to receive strong support, in particular, from US agencies such as the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine. Today, there continues to be a significant investment in addiction neuroscience research globally. However, the views of addiction treatment providers about the BDMA, and its clinical impact, are often ignored when debates led by public health researchers and neuroscientists dominate discourse about the neurobiology of addiction. In this chapter, we start by providing a brief history of the biomedicalization of addiction. Moving beyond the question of ‘Is addiction a brain disease, or not?’, we summarize providers’ views about the BDMA and its impact on clinical practice. Drawing on recent critical drug studies scholarship, we critique how a simplistic, linear ‘bench to bedside’ model of addiction neuroscience translation elides the role treatment providers play in translating neuroscience. Finally, we consider the effects of how the enactment of addiction as a brain disease within policy impacts treatment, and how addiction might be enacted in other ways in future policy frameworks. 2022-01-06T04:01:05Z 2022-01-06T04:01:05Z 2022-01-05T10:46:46Z 2022 chapter https://library.oapen.org/handle/20.500.12657/52200 9780367470043 9780367470067 https://directory.doabooks.org/handle/20.500.12854/75215 eng open access image/jpeg image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International Attribution-NonCommercial-NoDerivatives 4.0 International https://library.oapen.org/bitstream/20.500.12657/52200/1/9781003032762_10.4324_9781003032762-30.pdf https://library.oapen.org/bitstream/20.500.12657/52200/1/9781003032762_10.4324_9781003032762-30.pdf Taylor & Francis 10.4324/9781003032762-30 10.4324/9781003032762-30 fa69b019-f4ee-4979-8d42-c6b6c476b5f0 Evaluating the Brain Disease Model of Addiction 9780367470043 9780367470067 13 open access |
| spellingShingle | brain disease model; addiction; treatment thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics Barnett, Anthony Savic, Michael Pickersgill, Martyn O’Brien, Kerry Lubman, Dan I. Carter, Adrian Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title | Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title_full | Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title_fullStr | Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title_full_unstemmed | Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title_short | Chapter 26 Addiction treatment providers’ engagements with the Brain Disease Model of Addiction |
| title_sort | chapter 26 addiction treatment providers engagements with the brain disease model of addiction |
| topic | brain disease model; addiction; treatment thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics |
| topic_facet | brain disease model; addiction; treatment thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics |
| url | https://library.oapen.org/handle/20.500.12657/52200 |
| work_keys_str_mv | AT barnettanthony chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction AT savicmichael chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction AT pickersgillmartyn chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction AT obrienkerry chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction AT lubmandani chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction AT carteradrian chapter26addictiontreatmentprovidersengagementswiththebraindiseasemodelofaddiction |